Citadel Advisors - CENTURY THERAPEUTICS INC ownership

CENTURY THERAPEUTICS INC's ticker is IPSC and the CUSIP is 15673T100. A total of 57 filers reported holding CENTURY THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of CENTURY THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$124,782
+52.2%
62,391
+140.5%
0.00%
Q2 2023$81,986
-60.8%
25,945
-57.0%
0.00%
Q1 2023$209,241
-78.9%
60,300
-68.8%
0.00%
Q4 2022$991,927
+64.0%
193,358
+215.9%
0.00%
Q3 2022$605,000
+20.0%
61,200
+2.1%
0.00%
Q2 2022$504,000
+23.2%
59,966
+84.7%
0.00%
Q1 2022$409,000
-32.4%
32,458
+35.0%
0.00%
Q3 2021$605,00024,0440.00%
Other shareholders
CENTURY THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,307,407$2,614,8140.81%
Casdin Capital, LLC 3,206,380$6,412,7600.71%
Parametrica Management Ltd 27,840$55,6800.09%
Avidity Partners Management LP 1,098,500$2,197,0000.09%
Deep Track Capital, LP 543,008$1,086,0160.04%
HARBOURVEST PARTNERS LLC 29,018$58,0360.02%
CORNERCAP INVESTMENT COUNSEL INC 51,520$103,0400.02%
Baker Brothers Advisors 1,149,340$2,298,6800.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 165,000$330,0000.01%
FEDERATED HERMES, INC. 615,982$1,231,9640.00%
View complete list of CENTURY THERAPEUTICS INC shareholders